Widely read: First Page Personal Finance Stocks Ask Value Research Announcements IPO Analysis Fundwire Stockwire Newswire Learning

News & Announcements - Integrated Protein

Integrated Protein : Latest updates and developments

Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting.

Board Meeting Intimation for Audited Standalone Financial Results For The Quarter And Year Ended March 31 2026.

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Compliances-Reg.24(A)-Annual Secretarial Compliance

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Closure of Trading Window

Clarification On Price Movement

Top Picks

International funds open for investment right now

1 min read•By Value Research Team

Such a long journey

3 min read•By Dhirendra Kumar

Welcome to the New Value Research!

2 min read•By Value Research

I opened an NPS for the tax break. How do I get out?

4 min read•By Aakar Rastogi

Inheriting NPS is tax-free. Inheriting mutual funds isn't

3 min read•By Aakar Rastogi

Clarification sought from Integrated Proteins Ltd

Outcome Of The Meeting Of The Board Of Directors Held On Thursday 12Th February 2026 Pursuant To Regulation 30 & 33 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirement) Regulation 2015.

Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On Thursday 12Th February 2026 Pursuant To Regulation 30 & 33 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirement) Regulation 2015.

Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December 2025

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th December 2025

Closure of Trading Window

Explore Other Categories

See All Categories

Trading Approval Of 1 55 10 000 Equity Shares Of Rs. 10 Each Issued At Premium Of Rs. 1.25

18-Dec-2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

08-Nov-2025

Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended ('SEBI LODR').

07-Nov-2025

Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 And 33 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended ('SEBI LODR').

07-Nov-2025

Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30 September 2025.

04-Nov-2025

Non-Applicability Of Regulation 27(2) Of SEBI (LODR) Regulations 2015

16-Oct-2025

Load more

Name	Price Band (Rs)	Bidding Date
M R Maniveni Foods	51 - 52	22-May-2026 to 26-May-2026
Bio Medica Laboratories	132 - 139	21-May-2026 to 25-May-2026
Q-Line Biotech	326 - 343	21-May-2026 to 25-May-2026
Autofurnish	41	21-May-2026 to 25-May-2026

IPO Monitor